Analyze Diet
Veterinary parasitology1986; 20(1-3); 43-48; doi: 10.1016/0304-4017(86)90091-9

Species-specific serodiagnosis of equine piroplasma infections by means of complement fixation test (CFT), immunofluorescence (IIF), and enzyme-linked immunosorbent assay (ELISA).

Abstract: The increasing horse trade requires a reliable immunodiagnosis of equine piroplasma infections due to import restrictions imposed by various countries, including the United States of America. It was the aim of our investigations to establish the suitability of serological tests for the detection of parasite carriers and, eventually, to differentiate between Babesia caballi and B. equi infections. The investigations were carried out on 11 ponies with experimentally-induced B. caballi and/or B. equi infection. The infections were confirmed by the demonstration of parasites in blood smears 2-13 days post infection (PI). The complement fixation test (CFT), the indirect immunofluorescence (IIF) and the enzyme-linked immunosorbent assay (ELISA) were employed for the demonstration of antibodies, and different antigen preparations were tested for their suitability. Antibodies could be demonstrated by all three tests. Complement-fixing antibodies disappear after 2-3 months PI in B. caballi-infected horses, while the IIF and ELISA gave positive results during latent infection. A reliable serodiagnosis thus requires the use of the CFT and IIF, since parasite carriers may appear seronegative by the CFT. Serological differentiation between B. caballi and B. equi was possible by CFT and, to a certain extent, by IIF during early infection, but not by ELISA. The successful treatment of B. caballi infections with Berenil could only be confirmed serologically by IIF.
Publication Date: 1986-03-01 PubMed ID: 3518216DOI: 10.1016/0304-4017(86)90091-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on the development of effective serological tests to identify equine piroplasma infections in horses, especially infections caused by Babesia caballi and Babesia equi.

Background

  • The increasing global horse trade and various import restrictions by many countries, including the already stringent import conditions of the USA, necessitate reliable detection methods of equine piroplasma infections.
  • Piroplasma infections in horses, particularly those caused by Babesia caballi and Babesia equi, can be challenging to diagnose and differentiate.
  • These infections are confirmed by identifying parasites in blood smears, a technique which can yield results between 2-13 days following an infection (post-infection or PI).

Methodology

  • The research utilised an experimental infection model on 11 ponies with induced B. caballi and/or B. equi infections.
  • The authors employed three serological diagnostic tests: Complement fixation test (CFT), Indirect immunofluorescence (IIF), and Enzyme-linked immunosorbent assay (ELISA).
  • Researchers tested different antigen preparations to determine their suitability and efficacy for these tests.

Findings and Conclusions

  • All three diagnostic tests (CFT, IIF, and ELISA) successfully identified antibodies associated with the parasites.
  • The complement-fixing antibodies detected by the CFT test typically disappear after 2-3 months post-infection in B. caballi-infected horses.
  • However, both IIF and ELISA tests provided positive results during the latent stage of the infection.
  • To ensure a reliable diagnosis, the authors recommend the combined usage of CFT and IIF, as solely relying on CFT may result in false negatives in horses that carry the parasites but do not show symptoms.
  • The serological differentiation between B. caballi and B. equi was possible during early infection through CFT and to a lesser extent, through IIF, but not by ELISA.
  • Successful treatment of B. caballi infections with Berenil, a trypanocidal drug, could only be serologically confirmed using IIF.

Cite This Article

APA
Weiland G. (1986). Species-specific serodiagnosis of equine piroplasma infections by means of complement fixation test (CFT), immunofluorescence (IIF), and enzyme-linked immunosorbent assay (ELISA). Vet Parasitol, 20(1-3), 43-48. https://doi.org/10.1016/0304-4017(86)90091-9

Publication

ISSN: 0304-4017
NlmUniqueID: 7602745
Country: Netherlands
Language: English
Volume: 20
Issue: 1-3
Pages: 43-48

Researcher Affiliations

Weiland, G

    MeSH Terms

    • Animals
    • Antibodies / analysis
    • Antigens, Protozoan / immunology
    • Babesia / immunology
    • Babesiosis / diagnosis
    • Babesiosis / immunology
    • Babesiosis / parasitology
    • Complement Fixation Tests / veterinary
    • Cross Reactions
    • Enzyme-Linked Immunosorbent Assay / veterinary
    • Female
    • Fluorescent Antibody Technique / veterinary
    • Horse Diseases / diagnosis
    • Horse Diseases / immunology
    • Horse Diseases / parasitology
    • Horses
    • Immunoglobulin G / immunology
    • Male
    • Species Specificity

    Citations

    This article has been cited 19 times.
    1. Yang G, Chen K, Guo W, Hu Z, Qi T, Liu D, Wang Y, Du C, Wang X. Development of a Test Card Based on Colloidal Gold Immunochromatographic Strips for Rapid Detection of Antibodies against Theileria equi and Babesia caballi. Microbiol Spectr 2022 Feb 23;10(1):e0241121.
      doi: 10.1128/spectrum.02411-21pubmed: 35196786google scholar: lookup
    2. Onyiche TE, Suganuma K, Igarashi I, Yokoyama N, Xuan X, Thekisoe O. A Review on Equine Piroplasmosis: Epidemiology, Vector Ecology, Risk Factors, Host Immunity, Diagnosis and Control. Int J Environ Res Public Health 2019 May 16;16(10).
      doi: 10.3390/ijerph16101736pubmed: 31100920google scholar: lookup
    3. Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem 2012;19(10):1504-18.
      doi: 10.2174/092986712799828355pubmed: 22360483google scholar: lookup
    4. Huang X, Xuan X, Verdida RA, Zhang S, Yokoyama N, Xu L, Igarashi I. Immunochromatographic test for simultaneous serodiagnosis of Babesia caballi and B. equi infections in horses. Clin Vaccine Immunol 2006 May;13(5):553-5.
      doi: 10.1128/CVI.13.5.553-555.2006pubmed: 16682475google scholar: lookup
    5. Huang X, Xuan X, Xu L, Zhang S, Yokoyama N, Suzuki N, Igarashi I. Development of an immunochromatographic test with recombinant EMA-2 for the rapid detection of antibodies against Babesia equi in horses. J Clin Microbiol 2004 Jan;42(1):359-61.
      doi: 10.1128/JCM.42.1.359-361.2004pubmed: 14715778google scholar: lookup
    6. Tamaki Y, Hirata H, Takabatake N, Bork S, Yokoyama N, Xuan X, Fujisaki K, Igarashi I. Molecular cloning of a Babesia caballi gene encoding the 134-kilodalton protein and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2004 Jan;11(1):211-5.
    7. Huang X, Xuan X, Yokoyama N, Xu L, Suzuki H, Sugimoto C, Nagasawa H, Fujisaki K, Igarashi I. High-level expression and purification of a truncated merozoite antigen-2 of Babesia equi in Escherichia coli and its potential for immunodiagnosis. J Clin Microbiol 2003 Mar;41(3):1147-51.
    8. Hirata H, Ikadai H, Yokoyama N, Xuan X, Fujisaki K, Suzuki N, Mikami T, Igarashi I. Cloning of a truncated Babesia equi gene encoding an 82-kilodalton protein and its potential use in an enzyme-linked immunosorbent assay. J Clin Microbiol 2002 Apr;40(4):1470-4.
    9. Xuan X, Larsen A, Ikadai H, Tanaka T, Igarashi I, Nagasawa H, Fujisaki K, Toyoda Y, Suzuki N, Mikami T. Expression of Babesia equi merozoite antigen 1 in insect cells by recombinant baculovirus and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay. J Clin Microbiol 2001 Feb;39(2):705-9.
      doi: 10.1128/JCM.39.2.705-709.2001pubmed: 11158131google scholar: lookup
    10. Ikadai H, Xuan X, Igarashi I, Tanaka S, Kanemaru T, Nagasawa H, Fujisaki K, Suzuki N, Mikami T. Cloning and expression of a 48-kilodalton Babesia caballi merozoite rhoptry protein and potential use of the recombinant antigen in an enzyme-linked immunosorbent assay. J Clin Microbiol 1999 Nov;37(11):3475-80.
    11. Avarzed A, Igarashi I, De Waal DT, Kawai S, Oomori Y, Inoue N, Maki Y, Omata Y, Saito A, Nagasawa H, Toyoda Y, Suzuki N. Monoclonal antibody against Babesia equi: characterization and potential application of antigen for serodiagnosis. J Clin Microbiol 1998 Jul;36(7):1835-9.
    12. Ali S, Sugimoto C, Matsuda M, Sugiura T, Kanemaru T, Onuma M, Kamada M. Protein characterization of Babesia equi piroplasms isolated from infected horse erythrocytes. Parasitol Res 1993;79(8):639-43.
      doi: 10.1007/BF00932505pubmed: 8295900google scholar: lookup
    13. Böse R, Hentrich B. Identification of antigens diagnostic for European isolates of Babesia equi by two-dimensional electrophoresis and western blotting. Parasitol Res 1994;80(3):182-5.
      doi: 10.1007/BF00932671pubmed: 8036229google scholar: lookup
    14. Tenter AM, Otte MJ, Gonzalez CA, Abuabara Y. Prevalence of piroplasmosis in equines in the Colombian province of Cordoba. Trop Anim Health Prod 1988 May;20(2):93-8.
      doi: 10.1007/BF02242234pubmed: 3041656google scholar: lookup
    15. Gupta KK, Gupta N, Kumar S, Srivastava M, Kumar P. Equine piroplasmosis: an emerging tick-borne threat to equine health. Trop Anim Health Prod 2026 Jan 5;58(1):29.
      doi: 10.1007/s11250-025-04829-2pubmed: 41489672google scholar: lookup
    16. Wang T, Chen X, Yan X, Su Y, Gao W, Liu C, Wang W. Progress in serology and molecular biology of equine parasite diagnosis: sustainable control strategies. Front Vet Sci 2025;12:1663577.
      doi: 10.3389/fvets.2025.1663577pubmed: 40979365google scholar: lookup
    17. Axt CW, Springer A, von Luckner J, Naucke TJ, Müller E, Strube C, Schäfer I. [Equine piroplasmosis: Case descriptions and overview of the epidemiological situation in Europe with focus on Germany]. Tierarztl Prax Ausg G Grosstiere Nutztiere 2025 Feb;53(1):49-58.
      doi: 10.1055/a-2457-5516pubmed: 39631762google scholar: lookup
    18. Mendoza FJ, Pérez-Écija A, Kappmeyer LS, Suarez CE, Bastos RG. New insights in the diagnosis and treatment of equine piroplasmosis: pitfalls, idiosyncrasies, and myths. Front Vet Sci 2024;11:1459989.
      doi: 10.3389/fvets.2024.1459989pubmed: 39205808google scholar: lookup
    19. Axt CW, Springer A, Strube C, Jung C, Naucke TJ, Müller E, Schäfer I. Molecular and Serological Detection of Vector-Borne Pathogens Responsible for Equine Piroplasmosis in Europe between 2008 and 2021. Microorganisms 2024 Apr 17;12(4).